Applied Finance Capital Management, LLC Gilead Sciences, Inc. Transaction History
Applied Finance Capital Management, LLC
- $1.41 Trillion
- Q3 2025
A detailed history of Applied Finance Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Applied Finance Capital Management, LLC holds 15,040 shares of GILD stock, worth $1.87 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
15,040
Previous 16,096
6.56%
Holding current value
$1.87 Million
Previous $1.78 Billion
6.45%
% of portfolio
0.12%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...